Purchase Order 75N91021P00915
Award Date 9/24/21
Potential Completion Date 10/22/21
Potential Value $178K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute awarded a purchase order to Standard Biotools Inc. (doing business as Fluidigm) for $13,104.90 on July 3, 2018, with an ultimate completion date of July 3, 2019. The order, issued on a firm fixed price basis with no set-aside, procures antibodies. Place of performance is Bethesda, Maryland.</p>
- <p>The National Cancer Institute awarded a purchase order to Standard Biotools Inc. (doing business as Fluidigm) on September 7, 2017, with a ceiling value of $6,088.50. The order carries no set-aside designation. Place of performance is Bethesda, Maryland. The ultimate completion date is October 9, 2017. Pricing is firm fixed price. The specific requirements are not detailed in the source material.</p>
- <p>The National Cancer Institute awarded a purchase order to Standard Biotools Inc., doing business as Fluidigm, valued at $16,020.00, on May 7, 2018. No set-aside category was used. Place of performance is Bethesda, Maryland. The order has an ultimate completion date of July 10, 2019 and carries firm fixed pricing.</p>
- <p>The National Cancer Institute awarded a purchase order to Standard Biotools Inc. (doing business as Fluidigm) valued at $23,348.60 on August 24, 2018, with ultimate completion on August 23, 2019. No set-aside was used. Performance occurs in Bethesda, Maryland. The order is a firm fixed price commercial purchase; specific requirements are not detailed in the award notice.</p>
- <p>The National Cancer Institute issued a purchase order to Standard Biotools Inc. (doing business as Fluidigm) on March 24, 2021, with a ceiling value of $24,881.50 for staining services on formalin-fixed, paraffin-embedded (FFPE) tissue slides. Work is performed in Bethesda, Maryland, under firm fixed price terms with an ultimate completion date of April 30, 2021. No small business set-aside applies to this order.</p>
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $11,550 purchase order to Targetedbiosciences ORG Inc. to provide a service agreement for the Acculift laser capture microdissection system. The single award firm fixed price contract has a period of performance of one year, from November 3, 2023 through November 2, 2024. The place of performance will be in Bethesda, Maryland. No additional subcontractors or details regarding the...
- The National Cancer Institute awarded a purchase order to Fluxion Biosciences Inc. for $53,803.00 on September 21, 2020, under a total small business set-aside for procurement of a Fluxion Bioflux 200 microfluidic device system in support of the National Cancer Institute's Center for Cancer Research, Laboratory of Molecular Biology. The order is firm fixed price with an ultimate completion date of October 18, 2020. Place of performance is Alameda, California. The originating solicitation, posted...
- This contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), a civilian federal agency. The contract, valued at $137,800.00, is for a "C1 SYSTEM STANDARD SERVICE PLAN" and was awarded to the prime contractor, Standard Biotools Inc., doing business as Fluidigm. The contract type is a Firm Fixed Price Purchase Order, with a period of performance through March 6, 2021. The contract does not have a small business set-aside...
- <p>The National Cancer Institute awarded a purchase order to Microfluidic Chipshop GMBH for laboratory supplies on July 26, 2018, with a ceiling value of $19,414.50. Work is performed in Germany. The order is firm fixed price and was completed by September 30, 2019.</p>
- <p>The National Cancer Institute awarded a purchase order to Microfluidic Chipshop GMBH for $18,670.00 on August 24, 2017. The order is for lab supplies, to be performed in Jena-Lobeda, Germany, with an ultimate completion date of August 24, 2018. The procurement carries firm fixed price terms and was awarded without a small business set-aside.</p>